Maricann Group a low cost, greenhouse producer of medical cannabis with market leading technological, differentiation, appointed Gerhard Müller as an independent member of the Company's Board of Directors, subject to regulatory approval.
Müller is a former audit partner of Ernst & Young's German practice, responsible partner for the Technology, Media & Entertainment sector at Ernst & Young for the Germany, Switzerland, Austria (GSA) region.
A Certified Public Auditor and Tax Consultant, Müller studied economics and English in Munich and Manchester. At Ernst & Young, the majority of his clients were companies listed either in Europe or in the US.
He left Ernst & Young in 2013 and has been working in his own practice since then. Since July 2017, Müller is also Deputy Chair of the Supervisory board of m4e AG, a German listed media company.
Ben Ward, CEO Maricann Group, said: "We are pleased to welcome Gerhard to the Board of Directors of the Company. Gerhard's significant experience in international transactions, knowledge of reporting requirements and business structuring will help to ensure the execution of our strategy and reliability of our reporting.”
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Toronto with a facility in Langton, Ontario, where it operates a medicinal cannabis cultivation, extraction and distribution business under federal licence from the Government of Canada.
Maricann has federal licences to cultivate, process and distribute cannabis and services a patient base with more than 8000 total registered patients since inception.
